India to Kenya: Pomalidomide Export Trade Route

The India to Kenya Pomalidomide corridor is one of India's established pharmaceutical export routes, with 89 shipments documented worth a combined $38.5K USD. The route is dominated by R.S. SURGIPHARM PRIVATE LIMITED, which alone accounts for roughly 19% of all export value, reflecting the consolidated nature of India's pomalidomide manufacturing sector.

Across 19 active suppliers, the average shipment value stands at $432 USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 80% of all shipments, consistent with pomalidomide's non-urgent bulk-order profile.

Shipment activity peaks during July–September, with an average transit time of 27 days port-to-port. The route has recorded an annual growth rate of 31.0%, placing it at rank #19 among India's top pomalidomide export destinations globally.

On the import side, key buyers of Indian pomalidomide in Kenya include TO, MEDSERV AFRICA LTD,, FOR THE ORDER OF and 22 others. TO is the single largest importer with 17 shipments valued at $7.6K USD.

India's pomalidomide exports to Kenya are driven primarily by a handful of large-scale manufacturers. R.S. SURGIPHARM PRIVATE LIMITED with 15 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 19 active exporters signals a competitive but concentrated market — buyers in Kenya benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — R.S. SURGIPHARM PRIVATE LIMITED, PLASMA LIFE CARE, VAMA LIFECARE PRIVATE LIMITED — together account for 41% of total trade value on this route. The average shipment value of $432 USD reflects a mix of bulk commercial orders and smaller specialty shipments.

Beyond the primary product category, shipments on this route include closely related formulations such as pomalidomide cap 4 mg (total qty 10 pack and harmless medi. for human pomalidomide capsules 4mg 1*21 capsules batch no .:702765, suggesting that buyers in Kenya tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, TO is the largest importer with 17 shipments worth $7.6K USD — representing 20% of all pomalidomide imports from India on this route. A total of 25 buyers are active on this corridor.